Literature DB >> 22165704

[Pharmacotherapy of chronic heart failure after the first decade of 21st century].

J Spinar1, J Vítovec, L Spinarová.   

Abstract

We provide an overview of the main principles of pharmacological treatment of chronic heart failure. Chronic heart failure is considered to be an epidemic of the 21th century; in the Czech Republic, around 200,000 persons suffer from this condition. Over the last decade, pharmacological and non-pharmacological treatment of heart failure has undergone significant progress and new knowledge arises every year. Generally accepted pharmacological treatment steps include administration of ACE inhibitors, All antagonists (ARB) or beta-blockers, discussions exists on an indication for digoxin, diuretics and lipid-lowering drugs as well as on the importance of ACE-I and ARB. The role of antiarrhythmics is unclear and 2009-2011 have brought about some completely new drug groups-If, channel blockers, factor Xa blockers, thrombin blockers and other agents.

Entities:  

Mesh:

Year:  2011        PMID: 22165704

Source DB:  PubMed          Journal:  Vnitr Lek        ISSN: 0042-773X


  1 in total

1.  Angiotensin-converting enzyme inhibitors, angiotensin-II-receptor antagonists and angiotensin-receptor blocker/neprilysin inhibitor utilization in heart failure patients: Sub-analysis of a nation-wide population-based study in the Czech Republic.

Authors:  Renata Aiglova; Milos Taborsky; Marie Lazarova; Ludek Pavlu; Josef Danek; Jan Precek; Alexander Schee; Vit Gloger; Vlastimil Cernicek; Marek Vicha; Tomas Skala
Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub       Date:  2021-06-04       Impact factor: 1.648

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.